Kristin A. Connarn focuses her practice on life sciences patent prosecution and patent portfolio development and management in the fields of biotechnology and pharmaceuticals. Kristin advises clients on intellectual property (IP) issues, develops and delivers training sessions for employees and managers, and counsels in-house patent team members regarding invention disclosures. She has experience with preparing patentability, invalidity and non-infringement legal opinions, landscape and freedom to operate studies, due diligence, prior art searches and coordinating in-house patent committee meetings.
Kristin’s patent prosecution experience includes subject matter related to the following:
Human and humanized antibodies
Methods of treatment and diagnostics
Dry powder inhalation therapies
Kristin was previously a research associate in the Cancer Bioscience and CNS groups at AstraZeneca R&D Boston, where she employed molecular and cell biology techniques to research cancer and Alzheimer’s disease. She was also a laboratory technician with Transkaryotic Therapies, where she researched gene activation.
Kristin earned her bachelor’s degree in biotechnology. While in law school, she was book review editor for the Journal of High Technology Law.
Do not send any information or documents that you want to have treated as secret or confidential. Providing information to McDermott via email links on this website or other introductory email communications will not create an attorney-client relationship; will not preclude McDermott from representing any other person or firm in any matter; and will not obligate McDermott to keep confidential the information you provide. McDermott cannot enter into an attorney-client relationship with you until McDermott has determined that doing so will not create a conflict of interest and until you and McDermott have entered into a written agreement or engagement letter that sets forth the terms of our relationship.